<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" article-type="case-report" dtd-version="2.3" xml:lang="EN">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Med.</journal-id>
<journal-title>Frontiers in Medicine</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Med.</abbrev-journal-title>
<issn pub-type="epub">2296-858X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmed.2024.1512449</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Medicine</subject>
<subj-group>
<subject>Case Report</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Emphysematous pyelonephritis with rare and severe iliac vascular complications: a case report and review</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Gao</surname> <given-names>Pan</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="author-notes" rid="fn0001"><sup>&#x2020;</sup></xref>
<uri xlink:href="https://loop.frontiersin.org/people/2335280/overview"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" equal-contrib="yes">
<name><surname>Yang</surname> <given-names>Han</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="aff" rid="aff2"><sup>2</sup></xref>
<xref ref-type="author-notes" rid="fn0001"><sup>&#x2020;</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Zhang</surname> <given-names>Zhi</given-names></name>
<xref ref-type="aff" rid="aff1"><sup>1</sup></xref>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<role content-type="https://credit.niso.org/contributor-roles/writing-original-draft/"/>
<role content-type="https://credit.niso.org/contributor-roles/writing-review-editing/"/>
</contrib>
</contrib-group>
<aff id="aff1"><sup>1</sup><institution>Department of Urology, Second People's Hospital of Yichang, Second People's Hospital of China Three Gorges University</institution>, <addr-line>Yichang</addr-line>, <country>China</country></aff>
<aff id="aff2"><sup>2</sup><institution>Department of Urology, The Affiliated Hospital of Qingdao University</institution>, <addr-line>Qingdao</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by" id="fn0002">
<p>Edited by: Vittoria Mattioni Marchetti, University of Pavia, Italy</p>
</fn>
<fn fn-type="edited-by" id="fn0003">
<p>Reviewed by: Jad A. Degheili, Ibn Sina Hospital, Kuwait</p>
<p>Davide Costa, Magna Gr&#x00E6;cia University, Italy</p>
</fn>
<corresp id="c001">&#x002A;Correspondence: Zhi Zhang, <email>702032715@qq.com</email></corresp>
<fn fn-type="equal" id="fn0001"><p><sup>&#x2020;</sup>These authors have contributed equally to this work</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>13</day>
<month>01</month>
<year>2025</year>
</pub-date>
<pub-date pub-type="collection">
<year>2024</year>
</pub-date>
<volume>11</volume>
<elocation-id>1512449</elocation-id>
<history>
<date date-type="received">
<day>16</day>
<month>10</month>
<year>2024</year>
</date>
<date date-type="accepted">
<day>11</day>
<month>12</month>
<year>2024</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2025 Gao, Yang and Zhang.</copyright-statement>
<copyright-year>2025</copyright-year>
<copyright-holder>Gao, Yang and Zhang</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/">
<p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p>
</license>
</permissions>
<abstract>
<p>Emphysematous pyelonephritis (EPN) is a rare but severe necrotizing infection often associated with diabetes, ureteral obstruction, and gas production in the renal parenchyma and perinephric area. This report describes a 54-year-old man with type 2 diabetes who presented with right lumbar pain and was diagnosed with EPN complicated by right ureteral calculi and perinephric gas accumulation. Despite initial improvement with fluid resuscitation, antibiotics, and drainage, inadequate blood glucose control led to a worsening of the infection, eventually involving the psoas major muscle and iliac vessels. This progression resulted in the formation of an iliac aneurysm, which required endovascular surgery. The patient&#x2019;s recovery was supported by proper blood glucose management and targeted antibiotic therapy. This case highlights the importance of early recognition, appropriate management, and strict glycemic control in preventing severe complications of EPN.</p>
</abstract>
<kwd-group>
<kwd>emphysematous pyelonephritis</kwd>
<kwd>diabetes</kwd>
<kwd>ureteral calculi</kwd>
<kwd>aneurysm</kwd>
<kwd>iliac aneurysm</kwd>
</kwd-group>
<counts>
<fig-count count="3"/>
<table-count count="0"/>
<equation-count count="0"/>
<ref-count count="14"/>
<page-count count="4"/>
<word-count count="2631"/>
</counts>
<custom-meta-wrap>
<custom-meta>
<meta-name>section-at-acceptance</meta-name>
<meta-value>Nephrology</meta-value>
</custom-meta>
</custom-meta-wrap>
</article-meta>
</front>
<body>
<sec sec-type="intro" id="sec1">
<title>Introduction</title>
<p>Emphysematous pyelonephritis (EPN) is a rare but life-threatening infection of the kidney and perinephric area characterized by the presence of gas in the renal parenchyma, renal pelvis, or perinephric space (<xref ref-type="bibr" rid="ref1">1</xref>). It is often associated with uncontrolled diabetes, urinary tract obstruction, and immunocompromised states (<xref ref-type="bibr" rid="ref2">2</xref>). EPN has been linked to high mortality rates if not managed appropriately and in a timely manner (<xref ref-type="bibr" rid="ref3">3</xref>). In this report, we present a unique case of EPN complicated by severe iliac vascular involvement, which has never been reported in the literature. The pathogenesis, management challenges, and potential mechanisms for the development of such complications are discussed.</p>
</sec>
<sec id="sec2">
<title>Case presentation</title>
<p>A 54-year-old man with a 10-year history of type 2 diabetes mellitus presented to our hospital with a 5-day history of right lumbar pain. The patient had initially been treated with intravenous anti-inflammatory medication at another hospital, but his symptoms persisted and worsened. On presentation, his vital signs included a temperature of 36.2&#x00B0;C, a heart rate of 107 beats per minute, and a blood pressure of 94/73&#x202F;mmHg. The patient exhibited obvious percussion pain in the right renal area. Physical examination revealed no other significant findings.</p>
<p>Laboratory tests showed a white blood cell count of 11.3&#x202F;&#x00D7;&#x202F;10^9/L, a platelet count of 52&#x202F;&#x00D7;&#x202F;10^9/L, and elevated C-reactive protein (CRP) levels of 169.65&#x202F;mg/L, indicative of systemic inflammation. Renal function tests revealed a serum creatinine level of 179&#x202F;mmol/L and a blood urea nitrogen level of 18.7&#x202F;mg/dL, suggesting mild renal impairment. Urinalysis revealed leukocyturia of 2,102/&#x03BC;L and elevated procalcitonin (PCT) of 48.71&#x202F;ng/mL, indicating severe infection.</p>
<p>A contrast-enhanced CT scan of the abdomen and pelvis revealed right ureteral calculi complicated by emphysematous pyelonephritis (EPN). Gas was seen in the renal parenchyma, renal pelvis, and perinephric space, accompanied by right-sided hydronephrosis (<xref ref-type="fig" rid="fig1">Figures 1A</xref>,<xref ref-type="fig" rid="fig1">B</xref>). Given the severity of the findings, the patient was immediately started on broad-spectrum intravenous antibiotics and fluid resuscitation. Emergency percutaneous renal puncture drainage was performed, and foul-smelling pus with gas was drained from the right kidney. <italic>E. coli</italic> was cultured from both the urine and the pus, confirming the infectious etiology.</p>
<fig position="float" id="fig1">
<label>Figure 1</label>
<caption>
<p>Urinary CT revealed gas in the right renal parenchyma and perirenal with right hydronephrosis <bold>(A)</bold> and right ureteral calculi at the intersection with the iliac vessels <bold>(B)</bold>. Repeat CT showed a significant improvement in right hydronephrosis and pyelonephritis with reduced gas accumulation <bold>(C)</bold>.</p>
</caption>
<graphic xlink:href="fmed-11-1512449-g001.tif"/>
</fig>
<p>In the following days, the patient&#x2019;s condition improved with continued antibiotic therapy, aggressive fluid resuscitation, and insulin therapy to control blood glucose levels. After stabilization, the patient underwent a right ureteroscopy, lithotripsy, and double-J stent insertion. A follow-up CT scan performed 1&#x202F;week later (<xref ref-type="fig" rid="fig1">Figure 1C</xref>) showed a significant reduction in hydronephrosis and resolution of perinephric inflammation. At the time of discharge, after 2&#x202F;weeks of hospitalization, the patient&#x2019;s laboratory values had normalized, with stable renal function and blood glucose control. No bacterial growth was detected in two subsequent urine cultures. Given the absence of any evidence of infection in the patient, a double-J stent removal procedure was performed 3&#x202F;weeks after the patient was discharged from the hospital.</p>
<p>However, 1&#x202F;month after discharge, the patient returned to our center with recurrent right lumbar pain. He had not been adhering to the prescribed blood glucose control regimen at home. On physical examination, he had stable vital signs, but his blood glucose level was elevated to 26.9&#x202F;mmol/L. The laboratory results showed leukocytosis (11.1&#x202F;&#x00D7;&#x202F;10^9/L) and leukocyturia (277/&#x03BC;L), suggesting ongoing infection. A new contrast-enhanced CT scan revealed mild progression of hydronephrosis and increased perinephric inflammation (<xref ref-type="fig" rid="fig2">Figure 2</xref>). Blood cultures identified multidrug-resistant <italic>E. coli</italic>, prompting a change in antibiotic therapy.</p>
<fig position="float" id="fig2">
<label>Figure 2</label>
<caption>
<p>Urinary CT showed slightly more hydronephrosis in the right kidney and more perirenal inflammation than before <bold>(A)</bold>, and soft tissue density shadows are seen around the inferior vena cava and the right common iliac vessels <bold>(B)</bold>.</p>
</caption>
<graphic xlink:href="fmed-11-1512449-g002.tif"/>
</fig>
<p>Given the recurrence of infection, a double-J stent was reinserted, and the patient was started on insulin therapy for glycemic control. Despite these measures, the patient continued to experience significant right lumbar pain, and his inflammatory markers remained elevated. A contrast-enhanced CT scan performed shortly thereafter revealed a right common iliac artery aneurysm, with gas accumulation and soft tissue shadows adjacent to the right iliopsoas muscle (<xref ref-type="fig" rid="fig3">Figures 3A</xref>,<xref ref-type="fig" rid="fig3">B</xref>). The inferior vena cava was obscured by the inflammatory mass, suggesting the possibility of a contained rupture, thrombosis, or pneumocystis. The patient and his family hesitated regarding the proposed endovascular treatment of the aneurysm as they were concerned about potential complications.</p>
<fig position="float" id="fig3">
<label>Figure 3</label>
<caption>
<p>Contrast-enhanced CT findings: <bold>(A)</bold> The boundary between the lesion and the psoas major muscle, as well as the blood vessel, was unclear. A right common iliac aneurysm (red arrow), approximately 2.2 cm in diameter, and a right ureteral stent (blue arrow) were observed. <bold>(B)</bold> The right kidney appeared to be atrophied, irregularly shaped, and surrounded by mild inflammation. <bold>(C)</bold> Follow-up contrast-enhanced CT showed that the enhancement shadow around the iliac artery (yellow arrow) had significantly increased in size compared to the previous scan and exhibited an irregular shape. A mass-like shadow (red arrow) with a density lower than that of arterial blood vessels was observed, suggestive of rupture of the right common iliac aneurysm with localized encapsulation.</p>
</caption>
<graphic xlink:href="fmed-11-1512449-g003.tif"/>
</fig>
<p>Surprisingly, 2&#x202F;weeks later, a repeat contrast-enhanced CT scan (<xref ref-type="fig" rid="fig3">Figure 3C</xref>) showed that the aneurysm had ruptured but was contained by a surrounding fibrous capsule, preventing further hemorrhage. Fortunately, the right psoas muscle infection had improved. The patient underwent urgent endovascular surgery to repair the iliac aneurysm. Following surgery, the patient continued with appropriate fluid resuscitation, strict glycemic control, and tailored antibiotic therapy. His condition gradually stabilized, and he was discharged once again after his infection improved.</p>
</sec>
<sec sec-type="discussion" id="sec3">
<title>Discussion</title>
<p>Emphysematous pyelonephritis (EPN) is a rare but life-threatening infection characterized by the presence of gas in the renal parenchyma, renal pelvis, or perinephric space (<xref ref-type="bibr" rid="ref4">4</xref>). First described by Kelly and MacCallum in 1962 (<xref ref-type="bibr" rid="ref1">1</xref>), EPN is most commonly associated with uncontrolled diabetes mellitus, although other risk factors such as urinary tract obstruction, immunocompromised states, and female gender also play a role (<xref ref-type="bibr" rid="ref5">5</xref>, <xref ref-type="bibr" rid="ref6">6</xref>). The pathophysiology of EPN involves the fermentation of glucose by gas-producing bacteria, particularly <italic>Escherichia coli</italic> (<italic>E. coli</italic>), leading to the production of gas and tissue necrosis (<xref ref-type="bibr" rid="ref7">7</xref>). The disease has a high mortality rate if not promptly diagnosed and managed, especially when complicated by sepsis or other severe infections (<xref ref-type="bibr" rid="ref8">8</xref>).</p>
<p>In this case, the patient had a 10-year history of type 2 diabetes mellitus, which was poorly controlled, contributing significantly to the development of EPN. The patient&#x2019;s symptoms&#x2014;right lumbar pain and fever&#x2014;were typical of EPN, and the CT scan findings confirmed the diagnosis of right-sided EPN complicated by hydronephrosis and gas accumulation in the renal and perinephric spaces. The presence of gas in the renal parenchyma and perinephric space is a hallmark of EPN, and this finding is associated with a poor prognosis if not addressed promptly (<xref ref-type="bibr" rid="ref9">9</xref>). Early intervention with broad-spectrum antibiotics, fluid resuscitation, and percutaneous drainage was essential for the patient&#x2019;s initial recovery (<xref ref-type="bibr" rid="ref10">10</xref>).</p>
<p>However, the patient&#x2019;s poor glycemic control after discharge led to the recurrence of the infection and the development of severe complications. Despite initial improvement, the failure to maintain blood glucose within the recommended range resulted in the worsening of the infection, eventually leading to the formation of an iliac aneurysm, a rare but serious complication of EPN. To the best of our knowledge, this is the first reported case of EPN complicated by an iliac aneurysm. The presence of a vascular aneurysm in this setting is particularly concerning as it raises the risk of rupture, which could lead to life-threatening hemorrhage.</p>
<p>The mechanism by which EPN leads to aneurysm formation remains unclear, but it is likely related to the chronic infection and inflammatory process (<xref ref-type="bibr" rid="ref11">11</xref>). Inflammation of the psoas major muscle and iliac vessels, compounded by high glucose concentrations and tissue ischemia, may have contributed to endothelial damage, leading to the formation of an aneurysm. In addition, the gas-producing bacteria in EPN may further damage the vessel walls, weakening them and facilitating aneurysm formation. In our patient, the iliac aneurysm was initially contained, and the rupture was localized by a fibrous capsule, preventing massive hemorrhage. This contained rupture likely saved the patient&#x2019;s life and allowed for urgent endovascular repair, which ultimately resulted in a favorable outcome.</p>
<p>In the management of EPN, early diagnosis and intervention are critical to improving patient outcomes. The standard treatment for EPN includes broad-spectrum antibiotics, fluid resuscitation, and effective drainage of the infected kidney (<xref ref-type="bibr" rid="ref12">12</xref>). In severe cases, such as this one, where there is extensive vascular involvement or other life-threatening complications, multidisciplinary management is essential. Nephrectomy may be necessary in cases of non-functioning or severely damaged kidneys, but it should be reserved for patients who do not respond to medical treatment or when there is concern for ongoing infection or sepsis (<xref ref-type="bibr" rid="ref13">13</xref>). In our patient, despite the severe complications, conservative management with glycemic control, drainage, and surgery for the aneurysm ultimately resulted in recovery.</p>
<p>This case highlights the importance of strict blood glucose control in patients with diabetes as uncontrolled hyperglycemia is a significant risk factor for the development of EPN. In addition, it underscores the need for the early recognition of complications such as vascular involvement, which may not be apparent at the time of initial presentation. Regular follow-up and imaging are essential to detect recurrence or new complications, as seen in this patient.</p>
<p>The classification of EPN proposed by Huang and Tseng provides useful guidance for the management of the disease (<xref ref-type="bibr" rid="ref14">14</xref>). Based on their classification system, our patient would be categorized as type IIIb, which involves extensive perinephric and renal involvement with potential complications such as sepsis and vascular involvement. In such cases, a multidisciplinary approach is crucial, with the involvement of nephrologists, urologists, and vascular surgeons to address both the infection and any associated complications.</p>
<p>Finally, this case underscores the importance of patient education and compliance. Given the potential for severe complications, patients with diabetes must be closely monitored and educated about the importance of blood glucose control, adherence to prescribed therapies, and timely medical follow-up.</p>
</sec>
</body>
<back>
<sec sec-type="data-availability" id="sec4">
<title>Data availability statement</title>
<p>The raw data supporting the conclusions of this article will be made available by the authors, without undue reservation.</p>
</sec>
<sec sec-type="ethics-statement" id="sec5">
<title>Ethics statement</title>
<p>Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.</p>
</sec>
<sec sec-type="author-contributions" id="sec6">
<title>Author contributions</title>
<p>PG: Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. HY: Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing. ZZ: Writing &#x2013; original draft, Writing &#x2013; review &#x0026; editing.</p>
</sec>
<sec sec-type="funding-information" id="sec7">
<title>Funding</title>
<p>The author(s) declare that no financial support was received for the research, authorship, and/or publication of this article.</p>
</sec>
<sec sec-type="COI-statement" id="sec8">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec sec-type="ai-statement" id="sec9">
<title>Generative AI statement</title>
<p>The authors declare that no Gen AI was used in the creation of this manuscript.</p>
</sec>
<sec sec-type="disclaimer" id="sec10">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<ref-list>
<title>References</title>
<ref id="ref1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ubee</surname> <given-names>SS</given-names></name> <name><surname>McGlynn</surname> <given-names>L</given-names></name> <name><surname>Fordham</surname> <given-names>M</given-names></name></person-group>. <article-title>Emphysematous pyelonephritis</article-title>. <source>BJU Int</source>. (<year>2011</year>) <volume>107</volume>:<fpage>1474</fpage>&#x2013;<lpage>8</lpage>. doi: <pub-id pub-id-type="doi">10.1111/j.1464-410X.2010.09660.x</pub-id>, PMID: <pub-id pub-id-type="pmid">20840327</pub-id></citation></ref>
<ref id="ref2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zeng</surname> <given-names>L</given-names></name> <name><surname>Wang</surname> <given-names>Q</given-names></name> <name><surname>Wu</surname> <given-names>W</given-names></name></person-group>. <article-title>Emphysematous pyelonephritis</article-title>. <source>Am J Med Sci</source>. (<year>2022</year>) <volume>364</volume>:<fpage>e25</fpage>. doi: <pub-id pub-id-type="doi">10.1016/j.amjms.2022.04.001</pub-id>, PMID: <pub-id pub-id-type="pmid">35405140</pub-id></citation></ref>
<ref id="ref3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Zhang</surname> <given-names>M</given-names></name> <name><surname>Luo</surname> <given-names>H</given-names></name> <name><surname>Tan</surname> <given-names>S</given-names></name> <name><surname>Fei</surname> <given-names>T</given-names></name> <name><surname>Tang</surname> <given-names>Z</given-names></name> <name><surname>Li</surname> <given-names>Q</given-names></name> <etal/></person-group>. <article-title>Report on the diagnosis and treatment of 3 cases of emphysematous pyelonephritis with two different outcomes</article-title>. <source>Front Med (Lausanne)</source>. (<year>2024</year>) <volume>11</volume>:<fpage>1410014</fpage>. doi: <pub-id pub-id-type="doi">10.3389/fmed.2024.1410014</pub-id>, PMID: <pub-id pub-id-type="pmid">38994336</pub-id></citation></ref>
<ref id="ref4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Arrambide-Herrera</surname> <given-names>JG</given-names></name> <name><surname>Robles-Torres</surname> <given-names>JI</given-names></name> <name><surname>Oca&#x00F1;a-Mungu&#x00ED;a</surname> <given-names>MA</given-names></name> <name><surname>Romero-Mata</surname> <given-names>R</given-names></name> <name><surname>Guti&#x00E9;rrez-Gonz&#x00E1;lez</surname> <given-names>A</given-names></name> <name><surname>G&#x00F3;mez-Guerra</surname> <given-names>LS</given-names></name></person-group>. <article-title>Predictive factors for mortality and intensive care unit admission in patients with emphysematous pyelonephritis: 5-year experience in a tertiary care hospital</article-title>. <source>Actas Urol Esp (Engl Ed)</source>. (<year>2022</year>) <volume>46</volume>:<fpage>98</fpage>&#x2013;<lpage>105</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.acuro.2021.01.007</pub-id>, PMID: <pub-id pub-id-type="pmid">35120854</pub-id></citation></ref>
<ref id="ref5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Wu</surname> <given-names>SY</given-names></name> <name><surname>Yang</surname> <given-names>SSD</given-names></name> <name><surname>Chang</surname> <given-names>SJ</given-names></name> <name><surname>Hsu</surname> <given-names>CK</given-names></name></person-group>. <article-title>Emphysematous pyelonephritis: classification, management, and prognosis</article-title>. <source>Tzu Chi Med J</source>. (<year>2022</year>) <volume>34</volume>:<fpage>297</fpage>&#x2013;<lpage>302</lpage>. doi: <pub-id pub-id-type="doi">10.4103/tcmj.tcmj_257_21</pub-id>, PMID: <pub-id pub-id-type="pmid">35912050</pub-id></citation></ref>
<ref id="ref6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Otiniano</surname> <given-names>A</given-names></name> <name><surname>Tassin</surname> <given-names>C</given-names></name> <name><surname>Serris</surname> <given-names>A</given-names></name> <name><surname>Guennouni</surname> <given-names>N</given-names></name> <name><surname>Lanternier</surname> <given-names>F</given-names></name> <name><surname>Servais</surname> <given-names>A</given-names></name> <etal/></person-group>. <article-title>Emphysematous pyelonephritis in a diabetic patient</article-title>. <source>J Nephrol</source>. (<year>2023</year>) <volume>36</volume>:<fpage>2621</fpage>&#x2013;<lpage>4</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s40620-023-01639-3</pub-id>, PMID: <pub-id pub-id-type="pmid">37193924</pub-id></citation></ref>
<ref id="ref7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Craig</surname> <given-names>WD</given-names></name> <name><surname>Wagner</surname> <given-names>BJ</given-names></name> <name><surname>Travis</surname> <given-names>MD</given-names></name></person-group>. <article-title>Pyelonephritis: radiologic-pathologic review</article-title>. <source>Radiographics</source>. (<year>2008</year>) <volume>28</volume>:<fpage>255</fpage>&#x2013;<lpage>76</lpage>. doi: <pub-id pub-id-type="doi">10.1148/rg.281075171</pub-id>, PMID: <pub-id pub-id-type="pmid">18203942</pub-id></citation></ref>
<ref id="ref8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Somani</surname> <given-names>BK</given-names></name> <name><surname>Nabi</surname> <given-names>G</given-names></name> <name><surname>Thorpe</surname> <given-names>P</given-names></name> <name><surname>Hussey</surname> <given-names>J</given-names></name> <name><surname>Cook</surname> <given-names>J</given-names></name> <name><surname>N&#x2019;Dow</surname> <given-names>J</given-names></name> <etal/></person-group>. <article-title>Is percutaneous drainage the new gold standard in the management of emphysematous pyelonephritis? Evidence from a systematic review</article-title>. <source>J Urol</source>. (<year>2008</year>) <volume>179</volume>:<fpage>1844</fpage>&#x2013;<lpage>9</lpage>. doi: <pub-id pub-id-type="doi">10.1016/j.juro.2008.01.019</pub-id>, PMID: <pub-id pub-id-type="pmid">18353396</pub-id></citation></ref>
<ref id="ref9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ngo</surname> <given-names>XT</given-names></name> <name><surname>Nguyen</surname> <given-names>TT</given-names></name> <name><surname>Dobbs</surname> <given-names>RW</given-names></name> <name><surname>Thai</surname> <given-names>MS</given-names></name> <name><surname>Vu</surname> <given-names>DH</given-names></name> <name><surname>Dinh</surname> <given-names>LQV</given-names></name> <etal/></person-group>. <article-title>Prevalence and risk factors of mortality in emphysematous pyelonephritis patients: a Meta-analysis</article-title>. <source>World J Surg</source>. (<year>2022</year>) <volume>46</volume>:<fpage>2377</fpage>&#x2013;<lpage>88</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s00268-022-06647-1</pub-id>, PMID: <pub-id pub-id-type="pmid">35802159</pub-id></citation></ref>
<ref id="ref10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lu</surname> <given-names>YC</given-names></name> <name><surname>Hong</surname> <given-names>JH</given-names></name> <name><surname>Chiang</surname> <given-names>BJ</given-names></name> <name><surname>Pong</surname> <given-names>YH</given-names></name> <name><surname>Hsueh</surname> <given-names>PR</given-names></name> <name><surname>Huang</surname> <given-names>CY</given-names></name> <etal/></person-group>. <article-title>Recommended initial antimicrobial therapy for emphysematous pyelonephritis: 51 cases and 14-year-experience of a tertiary referral center</article-title>. <source>Medicine (Baltimore)</source>. (<year>2016</year>) <volume>95</volume>:<fpage>e3573</fpage>. doi: <pub-id pub-id-type="doi">10.1097/MD.0000000000003573</pub-id>, PMID: <pub-id pub-id-type="pmid">27227920</pub-id></citation></ref>
<ref id="ref11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>McAlpine</surname> <given-names>K</given-names></name> <name><surname>Ryan</surname> <given-names>SE</given-names></name> <name><surname>Roberts</surname> <given-names>M</given-names></name> <name><surname>Vigil</surname> <given-names>HR</given-names></name></person-group>. <article-title>Gas in the inferior vena cava from severe emphysematous pyelonephritis</article-title>. <source>Can J Urol</source>. (<year>2020</year>) <volume>27</volume>:<fpage>10195</fpage>&#x2013;<lpage>8</lpage>. PMID: <pub-id pub-id-type="pmid">32333741</pub-id></citation></ref>
<ref id="ref12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Desai</surname> <given-names>R</given-names></name> <name><surname>Batura</surname> <given-names>D</given-names></name></person-group>. <article-title>A systematic review and meta-analysis of risk factors and treatment choices in emphysematous pyelonephritis</article-title>. <source>Int Urol Nephrol</source>. (<year>2022</year>) <volume>54</volume>:<fpage>717</fpage>&#x2013;<lpage>36</lpage>. doi: <pub-id pub-id-type="doi">10.1007/s11255-022-03131-6</pub-id>, PMID: <pub-id pub-id-type="pmid">35103928</pub-id></citation></ref>
<ref id="ref13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ranjan</surname> <given-names>SK</given-names></name> <name><surname>Navriya</surname> <given-names>SC</given-names></name> <name><surname>Kumar</surname> <given-names>S</given-names></name> <name><surname>Mittal</surname> <given-names>A</given-names></name> <name><surname>Bhirud</surname> <given-names>DP</given-names></name></person-group>. <article-title>Emphysematous cystitis: a case report and literature review of 113 cases</article-title>. <source>Urol Ann</source>. (<year>2021</year>) <volume>13</volume>:<fpage>312</fpage>&#x2013;<lpage>5</lpage>. doi: <pub-id pub-id-type="doi">10.4103/UA.UA_61_20</pub-id>, PMID: <pub-id pub-id-type="pmid">34421272</pub-id></citation></ref>
<ref id="ref14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>JJ</given-names></name> <name><surname>Tseng</surname> <given-names>CC</given-names></name></person-group>. <article-title>Emphysematous pyelonephritis: clinicoradiological classification, management, prognosis, and pathogenesis</article-title>. <source>Arch Intern Med</source>. (<year>2000</year>) <volume>160</volume>:<fpage>797</fpage>&#x2013;<lpage>805</lpage>. doi: <pub-id pub-id-type="doi">10.1001/archinte.160.6.797</pub-id>, PMID: <pub-id pub-id-type="pmid">10737279</pub-id></citation></ref>
</ref-list>
</back>
</article>